Reach the investors backing rounds like this
Backed by Beyond Impact · verified emails and LinkedIn on Datapile

Paleo Raises $2.3M After 613-Fold Cost Cut, Targets US Filing for Animal-Free Myoglobin - ascendants.in
Paleo is a Belgian precision fermentation startup that engineers yeast to produce myoglobin, a heme-containing protein that enhances the flavor of meat alternatives. The company aims to bridge the taste gap in plant-based meats and has significantly reduced production costs, making it a notable player in the alternative protein market.
Paleo Raises $2.3M After 613-Fold Cost Cut, Targets US Filing for Animal-Free Myoglobin ascendants.in

| Sep 21, 2026 | Novadip Biosciences | $12.0M | Convertible | Belgium |
| Sep 18, 2026 | TUSK IC | $15.0M | Series A | Belgium |
| Sep 10, 2026 | IVEX | $5.0M | Series A | Belgium |
| Sep 04, 2026 | Octave.energy | $10.6M | — | Belgium |
You just read who funded Paleo. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.